Department of Nutrition and Food Studies, Steinhardt School of Culture, Education, and Human Development, New York University, New York, NY, United States.
Department of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL, United States.
Am J Clin Nutr. 2023 Nov;118(5):892-910. doi: 10.1016/j.ajcnut.2023.08.022. Epub 2023 Sep 9.
A total of 374 million adults worldwide are living with prediabetes, 70% of whom will develop type 2 diabetes mellitus (T2DM) in their lifetime. Medical nutrition therapy (MNT) provided by a dietitian, such as that found in lifestyle interventions, has the potential to improve glycemic control and prevent progression to T2DM.
The objective of this systematic review was to examine the effectiveness of MNT provided by a dietitian, compared with standard care, on glycemic, cardiometabolic, and anthropometric outcomes in adults with prediabetes.
Searches were conducted for randomized controlled trials (RCTs) published between 1995 and 2022 using electronic databases MEDLINE, CINHAL, and Cochrane Central. The risk of bias was assessed using version 2 of the Cochrane risk-of-bias tool for RCTs. Meta-analyses were conducted using a random-effects model. The certainty of evidence was assessed for each outcome using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method, and a summary of findings table was created using the GRADEpro Guideline Development Tool.
Thirteen RCTs were included in the analysis, showcasing a variety of MNT interventions delivered by dietitians. Intervention durations ranged from 3 to 24 mo. Compared with standard care, MNT improved hemoglobin A1c (HbA1c) (mean difference [95% confidence interval]: -0.30% [-0.49, -0.12]) and fasting blood glucose (FBG) (-4.97 mg/dL [-6.24, -3.71]). Statistically significant improvements were found in anthropometrics (weight, body mass index, and waist circumference), cholesterol (total, high-, and low-density lipoproteins), and blood pressure (systolic and diastolic). No significant effect was found on T2DM or triglycerides. The certainty of evidence was moderate for FBG and low for HbA1c and incidence of T2DM.
In adults with prediabetes, MNT was effective in improving glycemic outcomes, anthropometrics, blood pressure, and most lipid levels. However, most studies had a risk of bias because of the randomization process or deviations from intended interventions. MNT plays a key role in improving cardiometabolic risk factors in adults with prediabetes.
This study was registered with the registration ID #351421, available from https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=351421.
全球共有 3.74 亿成年人患有前期糖尿病,其中 70%的人在其一生中会发展为 2 型糖尿病(T2DM)。营养师提供的医学营养疗法(MNT),例如在生活方式干预中发现的 MNT,有可能改善血糖控制并防止进展为 T2DM。
本系统评价的目的是检查营养师提供的 MNT 与标准护理相比,在前期糖尿病成年人的血糖、心血管代谢和人体测量结果方面的有效性。
使用电子数据库 MEDLINE、CINHAL 和 Cochrane Central 对 1995 年至 2022 年期间发表的随机对照试验(RCT)进行了检索。使用 Cochrane 偏倚风险工具(版本 2)评估了偏倚风险。使用随机效应模型进行了荟萃分析。使用 Grading of Recommendations, Assessment, Development and Evaluation(GRADE)方法评估了每个结局的证据确定性,并使用 GRADEpro 指南开发工具创建了一个发现摘要表。
共有 13 项 RCT 纳入分析,展示了营养师提供的各种 MNT 干预措施。干预持续时间从 3 个月到 24 个月不等。与标准护理相比,MNT 改善了糖化血红蛋白(HbA1c)(平均差异[95%置信区间]:-0.30%[-0.49, -0.12])和空腹血糖(FBG)(-4.97mg/dL[-6.24, -3.71])。在人体测量学(体重、体重指数和腰围)、胆固醇(总胆固醇、高-和低-密度脂蛋白)和血压(收缩压和舒张压)方面也发现了统计学上的显著改善。T2DM 或甘油三酯没有显著影响。FBG 的证据确定性为中度,HbA1c 和 T2DM 的证据确定性为低。
在前期糖尿病成年人中,MNT 有效改善血糖结果、人体测量学、血压和大多数血脂水平。然而,由于随机化过程或对预期干预措施的偏离,大多数研究存在偏倚风险。MNT 在改善前期糖尿病成年人的心血管代谢危险因素方面发挥着关键作用。
本研究在登记号#351421 下进行,可在 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=351421 处获取。